Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Aug;103(4):2016–2020. doi: 10.1111/j.1476-5381.1991.tb12369.x

Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia.

G A Kennett 1, G Curzon 1
PMCID: PMC1908188  PMID: 1912990

Abstract

1. 1-3(Chlorophenyl)piperazine (mCPP) (5 mg kg-1, i.p.) inhibited 2 h food intake in rats previously deprived of food for one day. Ten 5-hydroxytryptamine (5-HT) antagonists given s.c. opposed this hypophagic response. Calculated ID50 values correlated significantly with reported affinities (r = 0.81, n = 10, P less than 0.01) for 5-HT1C but not for 5-HT2, 5-HT1A, 5-HT1B or 5-HT1D receptors. 2. ID50 values of the ten antagonists against 5-hydroxytryptophan (5-HTP) + carbidopa-induced head shakes (a 5-HT2-mediated response) correlated significantly (r = 0.81, n = 10, P less than 0.01) with their affinities for 5-HT2 but not for 5-HT1A, 5-HT1B, 5-HT1C or 5-HT1D receptors. 3. ID50 values for inhibition of hypophagia and head shakes did not correlate significantly with each other. 4. Ratios of ID50 values against hypophagia and 5-HT2-mediated head shakes gave indices of relative in vivo potencies independent of differences in drug metabolism and disposition. These ratios correlated highly significantly (r = 0.91, n = 10, P less than 0.001) with the ratios of the affinities of the drugs for 5-HT1C (but not for 5-HT1A, 5-HT1B or 5-HT1B or 5-HT1D receptors) and with their affinities for 5-HT2 receptors. These results strongly support the hypothesis that mediation of mCPP-induced hypophagia is by stimulation of 5-HT1C receptors and the mediation of 5-HTP-induced head twitches by 5-HT2 receptors.

Full text

PDF
2016

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aulakh C. S., Zohar J., Wozniak K. M., Hill J. L., Murphy D. L. Long-term lithium treatment in rats attenuates m-chlorophenylpiperazine-induced decreases in food intake but not locomotor activity. Psychopharmacology (Berl) 1989;98(4):448–452. doi: 10.1007/BF00441940. [DOI] [PubMed] [Google Scholar]
  2. Bedard P., Pycock C. J. "Wet-dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacology. 1977 Oct;16(10):663–670. doi: 10.1016/0028-3908(77)90117-4. [DOI] [PubMed] [Google Scholar]
  3. Cohen M. L., Fuller R. W., Kurz K. D. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat. J Pharmacol Exp Ther. 1983 Nov;227(2):327–332. [PubMed] [Google Scholar]
  4. Conn P. J., Sanders-Bush E. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors. J Pharmacol Exp Ther. 1987 Aug;242(2):552–557. [PubMed] [Google Scholar]
  5. Hartig P. R. Molecular biology of 5-HT receptors. Trends Pharmacol Sci. 1989 Feb;10(2):64–69. doi: 10.1016/0165-6147(89)90080-1. [DOI] [PubMed] [Google Scholar]
  6. Hewson G., Leighton G. E., Hill R. G., Hughes J. Ketanserin antagonises the anorectic effect of DL-fenfluramine in the rat. Eur J Pharmacol. 1988 Jan 12;145(2):227–230. doi: 10.1016/0014-2999(88)90236-1. [DOI] [PubMed] [Google Scholar]
  7. Hewson G., Leighton G. E., Hill R. G., Hughes J. Quipazine reduces food intake in the rat by activation of 5-HT2-receptors. Br J Pharmacol. 1988 Oct;95(2):598–604. doi: 10.1111/j.1476-5381.1988.tb11681.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hoyer D. Functional correlates of serotonin 5-HT1 recognition sites. J Recept Res. 1988;8(1-4):59–81. doi: 10.3109/10799898809048978. [DOI] [PubMed] [Google Scholar]
  9. Hutson P. H., Donohoe T. P., Curzon G. Infusion of the 5-hydroxytryptamine agonists RU24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia. Psychopharmacology (Berl) 1988;95(4):550–552. doi: 10.1007/BF00172974. [DOI] [PubMed] [Google Scholar]
  10. Kennett G. A., Curzon G. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors. Psychopharmacology (Berl) 1988;96(1):93–100. doi: 10.1007/BF02431539. [DOI] [PubMed] [Google Scholar]
  11. Kennett G. A., Curzon G. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol. 1988 May;94(1):137–147. doi: 10.1111/j.1476-5381.1988.tb11508.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kennett G. A., Dourish C. T., Curzon G. 5-HT1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol. 1987 Sep 23;141(3):429–435. doi: 10.1016/0014-2999(87)90561-9. [DOI] [PubMed] [Google Scholar]
  13. Kennett G. A., Whitton P., Shah K., Curzon G. Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists. Eur J Pharmacol. 1989 May 30;164(3):445–454. doi: 10.1016/0014-2999(89)90252-5. [DOI] [PubMed] [Google Scholar]
  14. Kłodzińska A., Chojnacka-Wójcik E. Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats. Pol J Pharmacol Pharm. 1990 Jan-Feb;42(1):13–17. [PubMed] [Google Scholar]
  15. Leysen J. E., Niemegeers C. J., Tollenaere J. P., Laduron P. M. Serotonergic component of neuroleptic receptors. Nature. 1978 Mar 9;272(5649):168–171. doi: 10.1038/272168a0. [DOI] [PubMed] [Google Scholar]
  16. Lucki I., Ward H. R., Frazer A. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. J Pharmacol Exp Ther. 1989 Apr;249(1):155–164. [PubMed] [Google Scholar]
  17. Neill J. C., Cooper S. J. Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors. Psychopharmacology (Berl) 1989;97(2):213–218. doi: 10.1007/BF00442252. [DOI] [PubMed] [Google Scholar]
  18. Samanin R., Mennini T., Ferraris A., Bendotti C., Borsini F., Garattini S. Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn Schmiedebergs Arch Pharmacol. 1979 Aug;308(2):159–163. doi: 10.1007/BF00499059. [DOI] [PubMed] [Google Scholar]
  19. Schechter L. E., Simansky K. J. 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats. Psychopharmacology (Berl) 1988;94(3):342–346. doi: 10.1007/BF00174687. [DOI] [PubMed] [Google Scholar]
  20. Schlicker E., Fink K., Göthert M., Hoyer D., Molderings G., Roschke I., Schoeffter P. The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jul;340(1):45–51. doi: 10.1007/BF00169206. [DOI] [PubMed] [Google Scholar]
  21. Schoeffter P., Hoyer D. Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist? Naunyn Schmiedebergs Arch Pharmacol. 1989 Jun;339(6):675–683. doi: 10.1007/BF00168661. [DOI] [PubMed] [Google Scholar]
  22. Schoeffter P., Waeber C., Palacios J. M., Hoyer D. The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra. Naunyn Schmiedebergs Arch Pharmacol. 1988 Jun;337(6):602–608. doi: 10.1007/BF00175784. [DOI] [PubMed] [Google Scholar]
  23. Shor-Posner G., Grinker J. A., Marinescu C., Brown O., Leibowitz S. F. Hypothalamic serotonin in the control of meal patterns and macronutrient selection. Brain Res Bull. 1986 Nov;17(5):663–671. doi: 10.1016/0361-9230(86)90198-x. [DOI] [PubMed] [Google Scholar]
  24. Waeber C., Dietl M. M., Hoyer D., Probst A., Palacios J. M. Visualization of a novel serotonin recognition site (5-HT1D) in the human brain by autoradiography. Neurosci Lett. 1988 May 16;88(1):11–16. doi: 10.1016/0304-3940(88)90307-2. [DOI] [PubMed] [Google Scholar]
  25. Yap C. Y., Taylor D. A. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat. Neuropharmacology. 1983 Jul;22(7):801–804. doi: 10.1016/0028-3908(83)90123-5. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES